Beam Therapeutics (BEAM) AI Analysis

BEAM$22.83-1.20 -4.99%
BiotechnologyGrowth Stock
Compare
Market cap$2.36BEnterprise value$2.90BRevenue (TTM)$146.64MMarket position—

Score

68
Bullish
Value
58
Quality
45
Growth
100

Beam Therapeutics is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 68/100) in Biotechnology. Under the hood: revenue compounding ~186% annually over recent years. Street targets still imply ~189% upside.

Beam Therapeutics (BEAM) AI Analysis

BEAM price $22.83 -1.20 -4.99%

Ticker
BEAM
Price
$22.83
Change
-1.20 -4.99%
Market cap
$2.36B
Dividend yield
0.00%
Beta
2.22
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
58
Quality
45
Growth
100

Stocklytics score rationale: value 58, quality 45, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener